Business Insights

Biomemory raises $18M in series A funding

By LabPulse.com staff writers

DNA data storage firm Biomemory announced that it has raised $18 million in series A funding.

December 10, 2024

BioMérieux's Biofire tropical fever panel gets special 510(k) clearance

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has granted special 510(k) clearance to BioMérieux's syndromic tropical fever panel, developed in conjunction with U.S. government agencies.

December 9, 2024

T2 Biosystems to license pathogen-detection technology

By LabPulse.com staff writers

T2 Biosystems plans to license its proprietary technology for the detection of sepsis-causing pathogens from whole blood.

December 9, 2024

WHO grants 1st prequalification to Cepheid TB test

By LabPulse.com staff writers

The World Health Organization (WHO) has granted prequalification to Cepheid’s molecular diagnostic tuberculosis (TB) test.

December 6, 2024

Amgen to open second N.C. manufacturing facility

By LabPulse.com staff writers

Biotech firm and drug manufacturer Amgen has announced a $1 billion expansion in North Carolina, with plans to establish a second manufacturing facility in the state.

December 6, 2024

FDA grants breakthrough device designation to DeepUll's bloodstream infection test

By LabPulse.com staff writers

Diagnostics developer DeepUll has received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its rapid bloodstream infection test.

December 4, 2024

COUR Pharmaceuticals, Genentech sign agreement on autoimmune therapeutics development

By LabPulse.com staff writers

Clinical-stage biotech firm COUR Pharmaceuticals announced a strategic partnership and licensing agreement with Genentech for the development and commercialization of COUR's nanoparticle treatments for an undisclosed autoimmune disorder.

December 3, 2024

Devyser gets IVDR approval for fetal RHD test

By LabPulse.com staff writers

Devyser Diagnostics has received In Vitro Diagnostic Regulation (IVDR) certification for its noninvasive fetal rhesus D (RHD) screening test.

December 2, 2024

Kronos Bio announces layoffs, CEO transition

By LabPulse.com staff writers

Kronos Bio will lay off approximately 83% of its workforce as part of a previously announced cost-reduction strategy.

December 2, 2024

Cross-contamination in lab testing triggers needless recalls

By LabPulse.com staff writers

Cases raise awareness of the damaging consequences of erroneous microbiology laboratory testing results.

November 27, 2024

Jury awards Guardant nearly $293M in lawsuit against Natera

By LabPulse.com staff writers

A federal jury in the U.S. District Court for the Northern District of California ruled in favor of Guardant Health in a lawsuit the company filed against Natera in May 2021.

November 26, 2024

Google releases open version of health AI developer platform

By LabPulse.com staff writers

Tool supports medical AI imaging applications in pathology (Path Foundation), chest x-ray (CXR Foundation), and dermatology (Derm Foundation).

November 26, 2024

Page 1 of 196

Next Page